Korean traditional Chungkookjang improves body composition, lipid profiles and atherogenic indices in overweight/obese subjects: A double-blind, randomized, crossover, placebo-controlled clinical trial

European Journal of Clinical Nutrition

Volumn 70, Issue 10, 2016, Pages 1116-1122

  Byun, M S ^a   Yu, O K ^a   Cha, Y S ^a   Park, T S ^a  

^a Chonbuk National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH SENSITIVITY C REACTIVE PROTEIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ANTIOBESITY AGENT; CHUNGKOOKJANG; ISOFLAVONE DERIVATIVE; SOYBEAN PROTEIN;

ADULT; ANTHROPOMETRY; ARTICLE; ATHEROGENESIS; BODY COMPOSITION; BODY FAT; CARDIOVASCULAR RISK; CHUNGKOOKJANG; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DIETARY SUPPLEMENT; DOUBLE BLIND PROCEDURE; DYSLIPIDEMIA; FEMALE; HUMAN; LEAN BODY WEIGHT; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; RANDOMIZED CONTROLLED TRIAL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; BLOOD; BODY MASS; MORBID OBESITY; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; ANTHROPOMETRY; ANTI-OBESITY AGENTS; APOLIPOPROTEINS B; BODY COMPOSITION; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ISOFLAVONES; MALE; OBESITY, MORBID; SOYBEAN PROTEINS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84990026832     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2016.77     Document Type: Article

References (49)

1. World Health Organization. Available at: http://www. who. int/mediacentre/fact sheets/fs311/en/ (last accessed 17 April 2015).
2. Mirtaheri E, Namazi N, Alizadeh M, Sargheini N, Karimi S. Effects of dried licorice extract with low-calorie diet on lipid profile and atherogenic indices in overweight and obese subjects: A randomized controlled clinical trial. Eur J Integr Med 2015; 7: 287-293.
3. Misra A, Shrivastava U. Obesity and dyslipidemia in South Asians. Nutrients 2013; 5: 2708-2733.
4. Poss J, Custodis F, Werner C, Weingartner O, Bohm M, Laufs U. Cardiovascular disease and dyslipidemia: beyond LDL. Curr Pharm Des 2011; 17: 861-870.
5. Saper RB, David ME, Russell SP. Common dietary supplements for weight loss. Am Fam Physician 2004; 70: 1731-1740.
6. Sekizaki H, Yokosawa R, Chinen C, Adachi H, Yamane Y. Studies on zoospore attracting activity. II. Synthesis of isoflavones and their attracting activity to Aphanomyces euteiches zoospore. Biol Pharm Bull 1993; 16: 698-701.
7. Kritchevsky D. Dietary protein, cholesterol and atherosclerosis: A review of the early history. J Nutr 1995; 125: 589 S-593 S.
8. Allison DB, Gadbury G, Schwartz LG, Murugesan R, Kraker JL, Heshka S et al. A novel soy-based meal replacement formula for weight loss among obese individuals: A randomized controlled clinical trial. Eur J Clin Nutr 2003; 57: 514-522.
9. Deibert P, König D, Schmidt-Trucksaess A, Zaenker KS, Frey I, Landmann U et al. Weight loss without losing muscle mass in pre-obese and obese subjects induced by a high-soy-protein diet. Int J Obes Relat Metab Disord 2004; 28: 1349-1352.
10. Su CL, Wu CJ, Chen FN, Wang BJ, Sheu SR, Won SJ. Supernatant of bacterial fermented soybean induces apoptosis of human hepatocellular carcinoma Hep 3B cells via activation of caspase 8 and mitochondria. Food Chem Toxicol 2007; 45: 303-314.
11. Kim YS, Yun SH, Jeong DY, Hahn KS, Uhm TB. Isolation of Bacillus licheniformis producing antimicrobial agents against Bacillus cereus and its properties. Kor J Microbiol 2010; 46: 270-277.
12. Hwang IS, Kim JE, Lee YJ, Kwak MH, Go J, Son HJ et al. Fermented soybean product (Cheonggukjang) improved some attributes of protein and growth hormone measurements in Sprague-Dawley rats. Nutr Res 2014; 34: 355-367.
13. Kwon DY, Jang JS, Lee JE, Kim YS, Shin DH, Park S. The isoflavonoid aglycone-rich fractions of Chungkukjang, fermented unsalted soybean, enhance insulin signaling and peroxisome proliferation-activated receptor-gamma activity in vitro. Biofactors 2006; 26: 245-258.
14. Nakajima N, Nozaki N, Ishihara K, Ishikawa A, Tsuji H. Analysis of isoflavone content in tempeh, a fermented soybean, and preparation of a new isoflavoneenriched tempeh. J Biosci Bioeng 2005; 100: 685-687.
15. Kim Y, Cho JY, Kuk JH, Moon JH, Cho JI, Kim YC et al. Identification and antimicrobial activity of phenylacetic acid produced by Bacillus licheniformis isolated from fermented soybean, Chungkook-Jang. Curr Microbiol 2004; 48: 312-317.
16. Lee JJ, Lee DS, Kim HB. Fermentation patterns of Chungkookjang and Kanjang by Bacillus licheniformis B1. Kor J Microbiol 1999; 35: 269-301.
17. Soh JR, Kwon DY, Cha YS. Hepatic gene expression profiles are altered by dietary unsalted Korean fermented soybean (Chungkookjang) consumption in mice with diet-induced obesity. J Nutr Metab 2011; 2011: 260214.
18. Kim DJ, Jeong YJ, Kwon JH, Moon KD, Kim HJ, Jeon SM et al. Beneficial effect of chungkukjang on regulation blood glucose and pancreatic-cell functions in C75BL/KsJ-db/db mice. J Med Food 2008; 11: 215-223.
19. Choi YH, Lim H, Heo MY, Kwon DY, Kim HP. Anti-inflammatory activity of the ethanol extract of Chungkukjang, Korean fermented bean: 5-lipoxygenase inhibition. J Med Food 2008; 11: 539-543.
20. Lee YJ, Kim JE, Kwak MH, Go J, Son HJ, Kim DS et al. In vitro and in vivo study of effects of fermented soybean product (chungkookjang) on NGF secretion ability and NGF receptor signaling pathway. Lab Anim Res 2013; 29: 113-126.
21. Fleiss JLThe Design and Analysis of Clinical Experiments. Wiley: London, UK, 1986.
22. Salari Moghaddam A, Entezari MH, Iraj B, Askari G, Sharifi Zahabi E, Maracy MR. The effects of soy bean flour enriched bread intake on anthropometric indicesand blood pressure in type 2 diabetic women: A crossover randomized controlled clinical trial. Int J Endocrinol 2014; 2014: 240760.
23. Back HI, Ha KC, Kim HM, Kim MG, Yu OK, Byun MS et al. The influence of the Korean traditional Chungkookjang on variables of metabolic syndrome in overweight/obese subjects: study protocol. BMC Complement Altern Med 2013; 13: 297.
24. Bhathena SJ, Velasquez MT. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 2002; 76: 1191-1201.
25. Goodman Gruen D, Kritz Silverstein D. Usual dietary isoflavone intake and body composition in postmenopausal women. Menopause 2003; 10: 427-432.
26. Azadbakht L, Nurbakhsh S. Effect of soy drink replacement in a weight reducing diet on anthropometric values and blood pressure among overweight and obese female youths. Asia Pac J Clin Nutr 2011; 20: 383-389.
27. Velasquez MT, Bhathena SJ. Role of dietary soy protein in obesity. Int J Med Sci 2007; 4: 72-82.
28. Jang CH, Park CS, Lim JK, Kim JH, Kwon DY, Kim YS. Metabolism of isoflavone derivatives during manufacturing of traditional meju and doenjang. Food Sci Biotechnol 2008; 17: 442-425.
29. Sapbamrer R, Visavarungroj N, Suttajit M. Effects of dietary traditional fermented soybean on reproductive hormones, lipids, and glucose among postmenopausal women in northern Thailand. Asia Pac J Clin Nutr 2013; 22: 222-228.
30. St-Onge MP, Claps N, Wolper C, Heymsfield SB. Supplementation with soy-proteinrich foods does not enhance weight loss. J Am Diet Assoc 2007; 107: 500-505.
31. Maesta N, Nahas EA, Nahas-Neto J, Orsatti FL, Fernandes CE, Traiman P et al. Effects of soy protein and resistance exercise on body composition and blood lipids in postmenopausal women. Maturitas 2007; 56: 350-358.
32. Hermansen K, Sondergaard M, Hoie L, Carstensen M, Brock B. Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care 2001; 24: 228-233.
33. Wagner JD, Zhang L, Greaves KA, Shadoan MK, Schwenke DC. Soy protein reduces the arterial low-density lipoprotein (LDL) concentration and delivery of LDL cholesterol to the arteries of diabetic and nondiabetic male cynomolgus monkeys. Metabolism 2000; 49: 1188-1196.
34. Kwon TW, Song YS, Kim JS, Moon GS, Kim JI, Hong JH. Current research on the bioactive functions of soyfoods in Korea. Kor Soybean Dig 1998; 15: 147-160.
35. Weissglas-Volkov D, Pajukanta P. Genetic causes of high and low serum HDL-cholesterol. J Lipid Res 2010; 51: 2032-2057.
36. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): A prospective study. Lancet 2001; 358: 2026-2033.
37. McQueen MJ, Hawken S, Wang X, Ounpuu S, Sniderman A, Probstfield J et al., INTERHEART study investigators. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): A case-control study. Lancet 2008; 372: 224-223.
38. Sniderman AD, Williams K, Contois JH, Monroe HM, McQueen MJ, de Graaf J et al. A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk. Circ Cardiovasc Qual Outcomes 2011; 4: 337-345.
39. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res 1995; 36: 211-228.
40. Gwak JH, Lee JH, Lee SJ, Park HW, Kim Y, Hyun YJ. The effect of L-carnitine and isoflavone supplementation on weight reduction and visceral fat accumulation in overweight women. Kor J Nutr 2007; 40: 630-638.
41. Kanazawa T, Osanai T, Zhang XS, Uemura T, Yin XZ, Onodera K et al. Protective effects of soy protein on the peroxidizability of lipoproteins in cerebrovascular diseases. J Nutr 1995; 125: 639 S-646 S.
42. Jialal I, Devaraj S. The role of oxidized low density lipoprotein in atherogenesis. J Nutr 1996; 126: 1053 S-1057 S.
43. Geng Y, Zhang B, Lotz M. Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes. J Immunol 1993; 151: 6692-6700.
44. Burke AP, Tracy RP, Kolodgie F, Malcom GT, Zieske A, Kutys R et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: Association with different pathologies. Circulation 2002; 105: 2019-2023.
45. Sharma SK, Mishra HK, Sharma H, Goel A, Sreenivas V, Gulati V et al. Obesity, and not obstructive sleep apnea, is responsible for increased serum hs-CRP levels in patients with sleep-disordered breathing in Delhi. Sleep Med 2008; 9: 149-156.
46. Raitakari OT, Mäkinen VP, McQueen MJ, Niemi J, Juonala M, Jauhiainen M et al. Computationally estimated apolipoproteins B and A1 in predicting cardiovascular risk. Atherosclerosis 2013; 226: 245-251.
47. Back HI, Kim SR, Yang JA, Kim MG, Chae SW, Cha YS. Effects of Chungkookjang supplementation on obesity and atherosclerotic indices in overweight/obese subjects: A 12-week, randomized, double-blind, placebo-controlled clinical trial. J Med Food 2011; 14: 532-537.
48. Sugano M, Goto S, Yamada Y, Yoshida K, Hashimoto Y, Matsuo T et al. Cholesterol-lowering activity of various undigested fractions of soybean protein in rats. J Nutr 1990; 120: 977-985.
49. Potter SM. Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J Nutr 1995; 125: 606-611.